Case Study: Leading Pharmaceutical Company Gains Deep Voice-of-Patient Insights with Quid

Leading Pharmaceutical Company - Customer Case Study

Leading Pharmaceutical Company partnered with Quid to better understand the mindset of patients living with major depressive disorder, including how they discuss symptoms, treatments, and depression drug classes. The company needed a clearer view into real patient voice and preferences to inform its understanding of the market and unmet needs.

Quid analyzed more than 15,000 online patient forum conversations and drug reviews from 2018–2019, building a patient conversation network and mapping the most discussed themes, drug classes, and specific medications. The analysis surfaced panic attacks and sleep issues as the most important patient experiences, showed SSRIs as the most discussed drug class with 3,006 posts and 1,258 patients, and highlighted strong engagement and largely negative sentiment around SNRIs, especially Effexor and Cymbalta.